Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial

被引:27
|
作者
Lehmann, Ulrike [1 ]
Riedel, Annett [1 ]
Hirche, Frank [1 ]
Brandsch, Corinna [1 ]
Girndt, Matthias [2 ]
Ulrich, Christof [2 ]
Seibert, Eric [2 ]
Henning, Christian [3 ]
Glomb, Marcus A. [3 ]
Dierkes, Jutta [4 ]
Stangl, Gabriele I. [1 ]
机构
[1] Univ Halle Wittenberg, Inst Agr & Nutr Sci, Halle, Germany
[2] Univ Halle Wittenberg, Dept Internal Med 2, Halle, Germany
[3] Univ Halle Wittenberg, Food Chem, Inst Chem, Halle, Germany
[4] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway
关键词
Vitamin D; 25(OH)D-3; 24,25(OH)(2)D-3; Supplementation; Healthy subjects; Randomized controlled trial; SERUM 25-HYDROXYVITAMIN D; GENETIC-DETERMINANTS; BIOAVAILABILITY; DIETARY; WOMEN; D-3; CALCIUM; CANCER;
D O I
10.1016/j.clnu.2015.04.021
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Large parts of the population are insufficiently supplied with vitamin D, in particular when endogenous synthesis is absent. Therefore many health care providers recommend the use of vitamin D supplements. The current study aimed to investigate the efficacy of an once-daily oral dose of 20 mu g vitamin D-3 to improve the vitamin D status and to evaluate predictors of response. Methods: The study was conducted as a double-blind, randomized, placebo-controlled parallel trial from January till April 2013. In total, 105 subjects (2-71 years) were allocated to receive either a vitamin D-3 supplement (20 mu g/d) or a placebo for 12 weeks. Circulating levels of vitamin D-3 metabolites such as the 25(OH)D-3 and the 24,25(OH)(2)D-3, and biomarkers of calcium and phosphate metabolism were quantified. Results: The 25(OH)D-3 serum concentrations in the placebo group decreased from 38 +/- 15 nmol/L at baseline to 32 +/- 14 nmol/L and 32 +/- 13 nmol/L at weeks 8 and 12 of the study, respectively (p < 0.01). In the vitamin D-3 group, the serum 25(OH)D-3 concentration increased from 38 +/- 14 nmol/L at baseline to 70 +/- 15 nmol/L and 73 +/- 16 nmol/L at weeks 8 and 12 of vitamin D-3 supplementation (p < 0.001), respectively. As a result, 94% of the vitamin D-3-supplemented participants reached 25(OH)D-3 concentrations of >= 50 nmol/L and thereof 46% attained 25(OH)D-3 levels of >= 75 nmol/L until the end of the study. The extent of the 25(OH)D-3 increase upon vitamin D-3 supplementation depended on 25(OH)D-3 baseline levels, age, body weight and circulating levels of triglycerides. In contrast to 25(OH)D-3, the response of 24,25(OH)(2)D-3 to the vitamin D-3 treatment was affected only by baseline levels of 24,25(OH)(2)D-3 and age. Conclusions: The average improvement of 25(OH)D-3 levels in individuals who received 20 mu g vitamin D-3 per day during the winter months was 41 nmol/L compared to individuals without supplementation. As a result almost all participants with the vitamin D-3 supplementation attained 25(OH)D-3 concentrations of 50 nmol/L and higher. The suitability of 24,25(OH)(2)D-3 as a marker of vitamin D status needs further investigation. (C) 2015 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:351 / 358
页数:8
相关论文
共 50 条
  • [2] Reply - Letter to the Editor - Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial
    Stangl, Gabriele I.
    CLINICAL NUTRITION, 2016, 35 (06) : 1584 - 1584
  • [3] Vitamin D3 Supplementation and Childhood Diarrhea: A Randomized Controlled Trial
    Aluisio, Adam R.
    Maroof, Zabihullah
    Chandramohan, Daniel
    Bruce, Jane
    Mughal, M. Zulf
    Bhutta, Zulfiqar
    Walraven, Gijs
    Masher, Mohammad I.
    Ensink, Jeroen H. J.
    Manaseki-Holland, Semira
    PEDIATRICS, 2013, 132 (04) : E832 - E840
  • [4] A Randomized Trial of Vitamin D3 Supplementation in Children: Dose-Response Effects on Vitamin D Metabolites and Calcium Absorption
    Lewis, R. D.
    Laing, E. M.
    Gallant, K. M. Hill
    Hall, D. B.
    McCabe, G. P.
    Hausman, D. B.
    Martin, B. R.
    Warden, S. J.
    Peacock, M.
    Weaver, C. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (12): : 4816 - 4825
  • [5] A randomized controlled trial of vitamin D3 supplementation in African American women
    Aloia, JF
    Talwar, SA
    Pollack, S
    Yeh, J
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (14) : 1618 - 1623
  • [6] Effect of genetic factors on the response to vitamin D3 supplementation in the VIDARIS randomized controlled trial
    Slow, Sandy
    Pearson, John P.
    Florkowski, Christopher M.
    Elder, Peter A.
    Lewis, John G.
    Kennedy, Martin A.
    Murdoch, David R.
    NUTRITION, 2020, 75-76
  • [7] Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial
    Bislev, Lise Sofie
    Rodbro, Lene Langagergaard
    Rolighed, Lars
    Sikjaer, Tanja
    Rejnmark, Lars
    CALCIFIED TISSUE INTERNATIONAL, 2019, 104 (02) : 160 - 170
  • [8] Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial
    Lise Sofie Bislev
    Lene Langagergaard Rødbro
    Lars Rolighed
    Tanja Sikjaer
    Lars Rejnmark
    Calcified Tissue International, 2019, 104 : 160 - 170
  • [9] Topical vitamin D3: A randomized controlled trial (RCT)
    Bubshait, Dalal A.
    Al-Dakheel, Dakheel A.
    Alanii, Fawaz M.
    CLINICAL NUTRITION ESPEN, 2018, 27 : 16 - 19
  • [10] Vitamin D3 Supplementation and Upper Respiratory Tract Infections in a Randomized, Controlled Trial
    Rees, Judy R.
    Hendricks, Kristy
    Barry, Elizabeth L.
    Peacock, Janet L.
    Mott, Leila A.
    Sandler, Robert S.
    Bresalier, Robert S.
    Goodman, Michael
    Bostick, Roberd M.
    Baron, John A.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (10) : 1384 - 1392